RecruitingNot ApplicableNCT07507799

Low Versus Standard Volume EXORA Block in Laparoscopic Cholecystectomy

Analgesic Efficacy of Low-Volume Versus Standard-Volume 0.25% Bupivacaine for Ultrasound-Guided External Oblique and Rectus Abdominis Plane Block in Laparoscopic Cholecystectomy, A Randomized Non-Inferiority Trial


Sponsor

Fayoum University Hospital

Enrollment

96 participants

Start Date

Apr 12, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The original EXORA block used high local anesthetic volume (50 mL total), raising concerns about local anesthetic systemic toxicity (LAST). In such a bilaterally administered regional technique, evaluating the efficacy of a reduced-volume approach is warranted to maximize patient safety.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called EXORA block 15 and a procedure called EXORA block 25 for people with pain, postoperative and post operative analgesia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEXORA block 15

15 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block

PROCEDUREEXORA block 25

25 mL of bupivacaine 0.25% administered bilaterally by ultrasound guided EXORA block


Locations(1)

Fayoum University hospital

El Fayoum Qesm, Faiyum Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07507799


Related Trials